GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,654,574 | -0.2% | 33,325 | +19.7% | 0.01% | -14.3% |
| Q2 2023 | $1,657,117 | +4.8% | 27,832 | -0.3% | 0.01% | 0.0% |
| Q1 2023 | $1,580,822 | -24.0% | 27,910 | -0.3% | 0.01% | -30.0% |
| Q4 2022 | $2,079,560 | +21.3% | 28,000 | -2.7% | 0.01% | 0.0% |
| Q3 2022 | $1,714,000 | +6.9% | 28,776 | +0.8% | 0.01% | 0.0% |
| Q2 2022 | $1,603,000 | -23.7% | 28,549 | +0.3% | 0.01% | -28.6% |
| Q1 2022 | $2,101,000 | -2.6% | 28,475 | -4.6% | 0.01% | -6.7% |
| Q4 2021 | $2,156,000 | -5.6% | 29,856 | +0.1% | 0.02% | -21.1% |
| Q3 2021 | $2,285,000 | -0.1% | 29,820 | +1.0% | 0.02% | -9.5% |
| Q2 2021 | $2,288,000 | +22.8% | 29,515 | -2.3% | 0.02% | +5.0% |
| Q1 2021 | $1,863,000 | +3.8% | 30,202 | +9.8% | 0.02% | -16.7% |
| Q4 2020 | $1,794,000 | +3.0% | 27,508 | -22.5% | 0.02% | -17.2% |
| Q3 2020 | $1,742,000 | +4.4% | 35,512 | +3.6% | 0.03% | +7.4% |
| Q2 2020 | $1,669,000 | +219.7% | 34,294 | +162.5% | 0.03% | +125.0% |
| Q1 2020 | $522,000 | +22.2% | 13,064 | +81.7% | 0.01% | +71.4% |
| Q4 2019 | $427,000 | +14133.3% | 7,190 | +11883.3% | 0.01% | – |
| Q1 2018 | $3,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |